FDA Updates on Paxlovid for Health Care Providers

FDA Updates on Paxlovid for Health Care Providers

Food and drug administration authorized Paxlovid (nirmatrelvir and ritonavir) in December 2021 for the treatment method of gentle-to-average COVID-19 in grownups and pediatric clients (12 a long time of age and older weighing at minimum 40 kg) with good success of direct SARS-CoV-2 viral screening who are also at higher possibility for progression to serious […]